US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 429.930
  • +7.150+1.69%
Close May 13 16:00 ET
  • 429.930
  • 0.0000.00%
Pre 06:30 ET
110.94BMarket Cap27.90P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-2.33%10.17B
4.08%11.22B
4.08%11.22B
22.08%11.93B
21.43%11.24B
26.41%10.41B
43.24%10.78B
43.24%10.78B
40.37%9.77B
37.95%9.25B
-Cash and cash equivalents
-1.42%9.16B
-1.28%10.37B
-1.28%10.37B
21.14%11.11B
16.65%10.15B
22.23%9.29B
54.58%10.5B
54.58%10.5B
46.14%9.17B
43.51%8.7B
-Short-term investments
-9.86%1.01B
209.36%849.2M
209.36%849.2M
36.52%818M
96.88%1.09B
76.21%1.12B
-62.39%274.5M
-62.39%274.5M
-12.55%599.2M
-14.45%551.2M
Receivables
15.85%1.79B
8.40%1.56B
8.40%1.56B
11.08%1.54B
16.75%1.56B
19.72%1.55B
26.86%1.44B
26.86%1.44B
25.88%1.39B
43.45%1.33B
-Accounts receivable
15.85%1.79B
8.40%1.56B
8.40%1.56B
11.08%1.54B
16.75%1.56B
19.72%1.55B
26.86%1.44B
26.86%1.44B
25.88%1.39B
43.45%1.33B
Inventory
51.95%813.1M
60.40%738.8M
60.40%738.8M
77.41%688.7M
64.13%603.5M
57.89%535.1M
30.44%460.6M
30.44%460.6M
16.42%388.2M
14.33%367.7M
Prepaid assets
----
24.56%537.6M
24.56%537.6M
----
----
----
-2.38%431.6M
-2.38%431.6M
----
----
Other current assets
9.05%511.1M
13.31%84.3M
13.31%84.3M
-25.68%540.2M
-13.21%476.9M
-4.64%468.7M
25.68%74.4M
25.68%74.4M
58.77%726.9M
10.17%549.5M
Total current assets
2.49%13.29B
6.87%14.14B
6.87%14.14B
19.76%14.7B
20.60%13.87B
25.14%12.97B
38.43%13.23B
38.43%13.23B
38.62%12.27B
36.02%11.5B
Non current assets
Net PPE
2.60%1.49B
-0.20%1.45B
-0.20%1.45B
-1.84%1.43B
2.00%1.45B
0.81%1.45B
2.20%1.46B
2.20%1.46B
7.88%1.46B
6.00%1.42B
-Gross PPE
2.60%1.49B
6.39%2.64B
6.39%2.64B
-1.84%1.43B
2.00%1.45B
0.81%1.45B
7.01%2.48B
7.01%2.48B
7.88%1.46B
6.00%1.42B
-Accumulated depreciation
----
-15.73%-1.19B
-15.73%-1.19B
----
----
----
-14.65%-1.03B
-14.65%-1.03B
----
----
Goodwill and other intangible assets
13.67%1.92B
13.97%1.93B
13.97%1.93B
0.76%1.69B
21.77%1.69B
20.64%1.69B
20.64%1.69B
20.64%1.69B
19.73%1.68B
-0.92%1.39B
-Goodwill
0.00%1.09B
0.00%1.09B
0.00%1.09B
1.19%1.09B
8.56%1.09B
8.56%1.09B
8.56%1.09B
8.56%1.09B
7.29%1.08B
0.00%1B
-Other intangible assets
38.32%834.9M
39.15%839.9M
39.15%839.9M
0.00%603.6M
55.97%603.6M
50.90%603.6M
50.90%603.6M
50.90%603.6M
50.90%603.6M
-3.25%387M
Investments and advances
305.12%4.38B
2,126.20%2.5B
2,126.20%2.5B
--1.7B
--1.36B
--1.08B
--112.2M
--112.2M
----
----
Non current deferred assets
44.35%1.96B
45.33%1.81B
45.33%1.81B
48.71%1.73B
34.46%1.54B
43.83%1.36B
33.43%1.25B
33.43%1.25B
24.51%1.16B
20.05%1.14B
Other non current assets
104.84%875.7M
118.58%895.3M
118.58%895.3M
258.64%475.2M
247.76%442.7M
286.18%427.5M
269.68%409.6M
269.68%409.6M
75.45%132.5M
79.05%127.3M
Total non current assets
76.89%10.63B
74.65%8.59B
74.65%8.59B
58.51%7.03B
58.78%6.48B
54.27%6.01B
26.97%4.92B
26.97%4.92B
17.77%4.44B
8.36%4.08B
Total assets
26.05%23.92B
25.23%22.73B
25.23%22.73B
30.05%21.73B
30.59%20.35B
33.10%18.97B
35.13%18.15B
35.13%18.15B
32.39%16.71B
27.50%15.58B
Liabilities
Current liabilities
Payables
8.73%351.4M
9.31%702M
9.31%702M
196.22%375.9M
83.33%363M
86.18%323.2M
5.85%642.2M
5.85%642.2M
-0.75%126.9M
55.25%198M
-accounts payable
8.73%351.4M
20.07%364.9M
20.07%364.9M
196.22%375.9M
83.33%363M
86.18%323.2M
55.85%303.9M
55.85%303.9M
-0.75%126.9M
55.25%198M
-Total tax payable
----
-19.30%99.5M
-19.30%99.5M
----
----
----
-41.65%123.3M
-41.65%123.3M
----
----
-Other payable
----
10.51%237.6M
10.51%237.6M
----
----
----
7.29%215M
7.29%215M
----
----
Current accrued expenses
20.20%2.8B
29.62%2.32B
29.62%2.32B
28.39%2.91B
22.58%2.6B
35.19%2.33B
41.16%1.79B
41.16%1.79B
42.87%2.26B
42.96%2.12B
Current debt and capital lease obligation
----
-6.38%83.7M
-6.38%83.7M
----
----
----
11.47%89.4M
11.47%89.4M
----
----
-Current capital lease obligation
----
-6.38%83.7M
-6.38%83.7M
----
----
----
11.47%89.4M
11.47%89.4M
----
----
Current deferred liabilities
----
6.70%170.3M
6.70%170.3M
----
----
----
-7.05%159.6M
-7.05%159.6M
----
----
Other current liabilities
72.04%648.6M
337.12%273.2M
337.12%273.2M
45.05%316.2M
63.80%391M
31.77%377M
278.79%62.5M
278.79%62.5M
8.24%218M
5.45%238.7M
Current liabilities
25.43%3.8B
29.37%3.55B
29.37%3.55B
37.95%3.6B
31.14%3.35B
38.80%3.03B
28.02%2.74B
28.02%2.74B
36.31%2.61B
39.19%2.56B
Non current liabilities
Long term debt and capital lease obligation
-8.60%721.3M
-10.56%724.7M
-10.56%724.7M
-9.69%744.7M
-9.41%767.6M
-9.55%789.2M
-8.67%810.3M
-8.67%810.3M
-5.95%824.6M
-5.21%847.3M
-Long term capital lease obligation
-8.60%721.3M
-10.56%724.7M
-10.56%724.7M
-9.69%744.7M
-9.41%767.6M
-9.55%789.2M
-8.67%810.3M
-8.67%810.3M
-5.95%824.6M
-5.21%847.3M
Other non current liabilities
17.49%853.6M
-15.75%196.3M
-15.75%196.3M
257.88%869.3M
209.67%759.3M
145.11%726.5M
-23.18%233M
-23.18%233M
-18.21%242.9M
-16.88%245.2M
Total non current liabilities
3.91%1.57B
7.11%1.6B
7.11%1.6B
51.19%1.61B
39.76%1.53B
29.67%1.52B
25.67%1.5B
25.67%1.5B
-9.05%1.07B
-8.10%1.09B
Total liabilities
18.25%5.37B
21.51%5.15B
21.51%5.15B
41.79%5.21B
33.72%4.88B
35.62%4.54B
27.18%4.24B
27.18%4.24B
19.07%3.68B
20.61%3.65B
Shareholders'equity
Share capital
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
4.00%2.6M
4.00%2.6M
1.48%2.6M
0.35%2.6M
-common stock
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
0.00%2.6M
4.00%2.6M
4.00%2.6M
1.48%2.6M
0.35%2.6M
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
55.65%11.24B
55.49%10.14B
55.49%10.14B
60.83%9.17B
70.49%8.14B
82.26%7.22B
103.79%6.52B
103.79%6.52B
134.66%5.7B
202.36%4.77B
Paid-in capital
0.89%7.28B
0.86%7.45B
0.86%7.45B
1.58%7.34B
3.79%7.37B
4.18%7.22B
7.35%7.39B
7.35%7.39B
1.97%7.23B
-7.07%7.1B
Gains losses not affecting retained earnings
232.06%17.3M
-1,887.50%-14.3M
-1,887.50%-14.3M
-103.07%-3M
-169.22%-39.8M
-215.93%-13.1M
-94.97%800K
-94.97%800K
745.97%97.6M
328.55%57.5M
Total stockholders'equity
28.51%18.55B
26.36%17.58B
26.36%17.58B
26.73%16.51B
29.64%15.47B
32.32%14.43B
37.75%13.91B
37.75%13.91B
36.71%13.03B
29.76%11.93B
Total equity
28.51%18.55B
26.36%17.58B
26.36%17.58B
26.73%16.51B
29.64%15.47B
32.32%14.43B
37.75%13.91B
37.75%13.91B
36.71%13.03B
29.76%11.93B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -2.33%10.17B4.08%11.22B4.08%11.22B22.08%11.93B21.43%11.24B26.41%10.41B43.24%10.78B43.24%10.78B40.37%9.77B37.95%9.25B
-Cash and cash equivalents -1.42%9.16B-1.28%10.37B-1.28%10.37B21.14%11.11B16.65%10.15B22.23%9.29B54.58%10.5B54.58%10.5B46.14%9.17B43.51%8.7B
-Short-term investments -9.86%1.01B209.36%849.2M209.36%849.2M36.52%818M96.88%1.09B76.21%1.12B-62.39%274.5M-62.39%274.5M-12.55%599.2M-14.45%551.2M
Receivables 15.85%1.79B8.40%1.56B8.40%1.56B11.08%1.54B16.75%1.56B19.72%1.55B26.86%1.44B26.86%1.44B25.88%1.39B43.45%1.33B
-Accounts receivable 15.85%1.79B8.40%1.56B8.40%1.56B11.08%1.54B16.75%1.56B19.72%1.55B26.86%1.44B26.86%1.44B25.88%1.39B43.45%1.33B
Inventory 51.95%813.1M60.40%738.8M60.40%738.8M77.41%688.7M64.13%603.5M57.89%535.1M30.44%460.6M30.44%460.6M16.42%388.2M14.33%367.7M
Prepaid assets ----24.56%537.6M24.56%537.6M-------------2.38%431.6M-2.38%431.6M--------
Other current assets 9.05%511.1M13.31%84.3M13.31%84.3M-25.68%540.2M-13.21%476.9M-4.64%468.7M25.68%74.4M25.68%74.4M58.77%726.9M10.17%549.5M
Total current assets 2.49%13.29B6.87%14.14B6.87%14.14B19.76%14.7B20.60%13.87B25.14%12.97B38.43%13.23B38.43%13.23B38.62%12.27B36.02%11.5B
Non current assets
Net PPE 2.60%1.49B-0.20%1.45B-0.20%1.45B-1.84%1.43B2.00%1.45B0.81%1.45B2.20%1.46B2.20%1.46B7.88%1.46B6.00%1.42B
-Gross PPE 2.60%1.49B6.39%2.64B6.39%2.64B-1.84%1.43B2.00%1.45B0.81%1.45B7.01%2.48B7.01%2.48B7.88%1.46B6.00%1.42B
-Accumulated depreciation -----15.73%-1.19B-15.73%-1.19B-------------14.65%-1.03B-14.65%-1.03B--------
Goodwill and other intangible assets 13.67%1.92B13.97%1.93B13.97%1.93B0.76%1.69B21.77%1.69B20.64%1.69B20.64%1.69B20.64%1.69B19.73%1.68B-0.92%1.39B
-Goodwill 0.00%1.09B0.00%1.09B0.00%1.09B1.19%1.09B8.56%1.09B8.56%1.09B8.56%1.09B8.56%1.09B7.29%1.08B0.00%1B
-Other intangible assets 38.32%834.9M39.15%839.9M39.15%839.9M0.00%603.6M55.97%603.6M50.90%603.6M50.90%603.6M50.90%603.6M50.90%603.6M-3.25%387M
Investments and advances 305.12%4.38B2,126.20%2.5B2,126.20%2.5B--1.7B--1.36B--1.08B--112.2M--112.2M--------
Non current deferred assets 44.35%1.96B45.33%1.81B45.33%1.81B48.71%1.73B34.46%1.54B43.83%1.36B33.43%1.25B33.43%1.25B24.51%1.16B20.05%1.14B
Other non current assets 104.84%875.7M118.58%895.3M118.58%895.3M258.64%475.2M247.76%442.7M286.18%427.5M269.68%409.6M269.68%409.6M75.45%132.5M79.05%127.3M
Total non current assets 76.89%10.63B74.65%8.59B74.65%8.59B58.51%7.03B58.78%6.48B54.27%6.01B26.97%4.92B26.97%4.92B17.77%4.44B8.36%4.08B
Total assets 26.05%23.92B25.23%22.73B25.23%22.73B30.05%21.73B30.59%20.35B33.10%18.97B35.13%18.15B35.13%18.15B32.39%16.71B27.50%15.58B
Liabilities
Current liabilities
Payables 8.73%351.4M9.31%702M9.31%702M196.22%375.9M83.33%363M86.18%323.2M5.85%642.2M5.85%642.2M-0.75%126.9M55.25%198M
-accounts payable 8.73%351.4M20.07%364.9M20.07%364.9M196.22%375.9M83.33%363M86.18%323.2M55.85%303.9M55.85%303.9M-0.75%126.9M55.25%198M
-Total tax payable -----19.30%99.5M-19.30%99.5M-------------41.65%123.3M-41.65%123.3M--------
-Other payable ----10.51%237.6M10.51%237.6M------------7.29%215M7.29%215M--------
Current accrued expenses 20.20%2.8B29.62%2.32B29.62%2.32B28.39%2.91B22.58%2.6B35.19%2.33B41.16%1.79B41.16%1.79B42.87%2.26B42.96%2.12B
Current debt and capital lease obligation -----6.38%83.7M-6.38%83.7M------------11.47%89.4M11.47%89.4M--------
-Current capital lease obligation -----6.38%83.7M-6.38%83.7M------------11.47%89.4M11.47%89.4M--------
Current deferred liabilities ----6.70%170.3M6.70%170.3M-------------7.05%159.6M-7.05%159.6M--------
Other current liabilities 72.04%648.6M337.12%273.2M337.12%273.2M45.05%316.2M63.80%391M31.77%377M278.79%62.5M278.79%62.5M8.24%218M5.45%238.7M
Current liabilities 25.43%3.8B29.37%3.55B29.37%3.55B37.95%3.6B31.14%3.35B38.80%3.03B28.02%2.74B28.02%2.74B36.31%2.61B39.19%2.56B
Non current liabilities
Long term debt and capital lease obligation -8.60%721.3M-10.56%724.7M-10.56%724.7M-9.69%744.7M-9.41%767.6M-9.55%789.2M-8.67%810.3M-8.67%810.3M-5.95%824.6M-5.21%847.3M
-Long term capital lease obligation -8.60%721.3M-10.56%724.7M-10.56%724.7M-9.69%744.7M-9.41%767.6M-9.55%789.2M-8.67%810.3M-8.67%810.3M-5.95%824.6M-5.21%847.3M
Other non current liabilities 17.49%853.6M-15.75%196.3M-15.75%196.3M257.88%869.3M209.67%759.3M145.11%726.5M-23.18%233M-23.18%233M-18.21%242.9M-16.88%245.2M
Total non current liabilities 3.91%1.57B7.11%1.6B7.11%1.6B51.19%1.61B39.76%1.53B29.67%1.52B25.67%1.5B25.67%1.5B-9.05%1.07B-8.10%1.09B
Total liabilities 18.25%5.37B21.51%5.15B21.51%5.15B41.79%5.21B33.72%4.88B35.62%4.54B27.18%4.24B27.18%4.24B19.07%3.68B20.61%3.65B
Shareholders'equity
Share capital 0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M4.00%2.6M4.00%2.6M1.48%2.6M0.35%2.6M
-common stock 0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M0.00%2.6M4.00%2.6M4.00%2.6M1.48%2.6M0.35%2.6M
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings 55.65%11.24B55.49%10.14B55.49%10.14B60.83%9.17B70.49%8.14B82.26%7.22B103.79%6.52B103.79%6.52B134.66%5.7B202.36%4.77B
Paid-in capital 0.89%7.28B0.86%7.45B0.86%7.45B1.58%7.34B3.79%7.37B4.18%7.22B7.35%7.39B7.35%7.39B1.97%7.23B-7.07%7.1B
Gains losses not affecting retained earnings 232.06%17.3M-1,887.50%-14.3M-1,887.50%-14.3M-103.07%-3M-169.22%-39.8M-215.93%-13.1M-94.97%800K-94.97%800K745.97%97.6M328.55%57.5M
Total stockholders'equity 28.51%18.55B26.36%17.58B26.36%17.58B26.73%16.51B29.64%15.47B32.32%14.43B37.75%13.91B37.75%13.91B36.71%13.03B29.76%11.93B
Total equity 28.51%18.55B26.36%17.58B26.36%17.58B26.73%16.51B29.64%15.47B32.32%14.43B37.75%13.91B37.75%13.91B36.71%13.03B29.76%11.93B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept Gene Editing
Gene Editing
Intraday+1.27%